A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Trial details
- Registry ID
- NCT07659782
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung CancerNCT07659782 | VSTM | Phase 2 | Recruiting | 2027-06Estimated |
| A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerNCT07659795 | VSTM | Phase 2 | Recruiting | 2027-06Estimated |
| A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerNCT07644559 | VSTM | Phase 2 | Recruiting | 2027-06Estimated |
| A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsNCT07020221 | VSTM | Phase 1, Phase 2 | Recruiting | 2028-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |